clinical candidate - Robuta Search

https://www.prnewswire.com/news-releases/immunocore-and-glaxosmithkline-select-first-immtac-clinical-candidate-in-discovery-collaboration-564341271.html Immunocore and GlaxoSmithKline Select First ImmTAC Clinical Candidate in Discovery Collaboration /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer,... clinical candidate immunocore glaxosmithkline select first https://www.biospace.com/immunocore-and-glaxosmithkline-select-first-immtac-clinical-candidate-in-discovery-collaboration Immunocore And GlaxoSmithKline Select First ImmTAC Clinical Candidate In Discovery Collaboration -... clinical candidate immunocore glaxosmithkline select first https://www.biospace.com/press-releases/sharp-therapeutics-corp-nominates-clinical-candidate-for-gauchers-disease Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher's Disease - BioSpace gaucher s disease clinical candidate sharp therapeutics corp https://www.prnewswire.com/news-releases/alkahest-doses-first-subject-in-phase-2-clinical-trial-of-lead-candidate-in-patients-with-severe-alzheimers-disease-300813375.html Alkahest Doses First Subject in Phase 2 Clinical Trial of Lead Candidate in Patients with Severe... /PRNewswire/ -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today... https://www.rcsb.org/structure/6USX RCSB PDB - 6USX: Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C... Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer https://www.biospace.com/milliporesigma-launches-adc-expresstm-services-to-accelerate-pre-clinical-conjugation-candidate-selection MilliporeSigma Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate... Oct 24, 2025 - MilliporeSigma introduced its ADC Express TM services for the rapid production of ADCs, which can reduce the time needed to produce development grade... milliporesigma launches adc services https://www.psychologytoday.com/us/therapists/salmin-lenhart-greeley-co/1711730 Salmin Lenhart, Clinical Social Work Candidate, Greeley, CO, 80634 | Psychology Today Salmin Lenhart, Clinical Social Work Candidate, Greeley, CO, 80634, (970) 500-1670, I work with children, teens, adults, and families who are navigating... clinical social work greeley co salmin lenhart https://www.jpost.com/health-science/protein-based-covid-19-vaccine-candidate-gets-china-clinical-trial-nod-664729 Protein-based COVID-19 vaccine candidate gets China clinical trial nod | The Jerusalem Post More than ten vaccine candidates led by Chinese scientists have entered different stages of clinical trials. https://www.biospace.com/press-releases/amneal-highlights-positive-topline-results-from-confirmatory-clinical-study-of-biosimilar-candidate-to-xolairr-omalizumab-developed-by-kashiv-biosciences Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate... https://www.pasteur.fr/en/home/press-area/press-documents/intranasal-lentiviral-vaccine-candidate-lenti-s-protects-brain-and-lung-pre-clinical-animal-model The intranasal lentiviral vaccine candidate (Lenti-S) protects brain and lung in a pre-clinical... Mar 26, 2024 - The intranasal lentiviral vaccine candidate (Lenti-S) protects brain and lung in a pre-clinical animal model https://www.biospace.com/algiax-pharmaceuticals-announces-new-executive-team-and-clinical-trial-plan-for-lead-candidate-ap-325 Algiax Pharmaceuticals Announces New Executive Team and Clinical Trial Plan for Lead Candidate... May 7, 2019 - Algiax Pharmaceuticals Appoints Dr. Ingo Lehrke and Dr. Guido Koopmans as CEO and CSO. A Proof-of-Concept Study for Neuropathic Pain is planned to start in Q4... https://www.biospace.com/flare-therapeutics-to-present-new-translational-data-in-support-of-clinical-candidate-fx-909-s-phase-1-development-at-sitc-2023-annual-meeting Flare Therapeutics to Present New Translational Data in Support of Clinical Candidate FX-909's... Oct 31, 2023 - Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases,... https://www.newswire.ca/news-releases/bellus-health-initiates-phase-1-clinical-study-for-its-chronic-cough-drug-candidate-blu-5937-687641441.html BELLUS Health Initiates Phase 1 Clinical Study for its Chronic Cough Drug Candidate, BLU-5937 /CNW/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS Health" or the "Company"), a biopharmaceutical development company advancing novel therapeutics for conditions... https://www.prnewswire.com/news-releases/amira-pharmaceuticals-announces-the-nomination-of-an-orally-available-pre-clinical-candidate-in-a-new-lpa-related-program-an-autotaxin-inhibitor-111923634.html Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a... /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest... https://www.fool.com/investing/2020/12/21/curevac-launches-phase-3-clinical-trial-of-coronav/ CureVac Launches Specialized Phase 3 Clinical Trial of Coronavirus Vaccine Candidate | The Motley... Dec 21, 2020 - The company's mRNA-based vaccine will be tested on healthcare workers. phase 3 clinical trial https://www.mdpi.com/2076-393X/11/12/1846 In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by... Gonorrhea, a sexually transmitted disease caused by Neisseria gonorrhoeae, poses a significant global public health threat. Infection in women can be...